"10.1371_journal.pone.0045804","plos one","2012-09-21T00:00:00Z","Saskia C A de Jager; Brenda W C Bongaerts; Michael Weber; Adriaan O Kraaijeveld; Mat Rousch; Stefanie Dimmeler; Marja P van Dieijen-Visser; Kitty B J M Cleutjens; Patty J Nelemans; Theo J C van Berkel; Erik A L Biessen","Division of Biopharmaceutics, Leiden Amsterdam Centre for Drug Research, Leiden University, Leiden, The Netherlands; Department of Pathology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, Maastricht, The Netherlands; Department of Cardiology, Kerckhoff Heart Centre, Bad Nauheim, Germany; Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands; Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe-University Frankfurt, Frankfurt am Main, Germany; Department of Clinical Chemistry, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands","Conceived and designed the experiments: EB MW SD TvB. Performed the experiments: MR SdJ. Analyzed the data: BB. Contributed reagents/materials/analysis tools: MvD MW. Wrote the paper: BB SdJ. Reviewed and edited the manuscript: AK BB EB KC MvD MR MW PN SD SdJ TvB. Contributed to data analyses: PN. Contributed to discussion: AK BB EB PN SdJ TvB.","SD is founder and advisor of t2cure GmbH. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.","2012","09","Saskia C A de Jager","SCADJ",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
